Neuphoria Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapies for individuals affected by neuropsychiatric disorders. The company is advancing BNC210, an experimental drug candidate, for the treatment of social anxiety disorder and post-traumatic stress disorder.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.